tradingkey.logo

Evaxion Biotech A/S

EVAX
5.130USD
+0.210+4.27%
Close 12/26, 16:00ETQuotes delayed by 15 min
1.62BMarket Cap
LossP/E TTM
You can find the annual or quarterly income statement of Evaxion Biotech A/S here for insights into the performance and operational efficiency of Evaxion Biotech A/S.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q1
FY2019Q4
Total revenue
148.33%7.49M
-75.97%37.00K
-100.00%0.00
67.12%122.00K
--3.02M
--154.00K
--51.00K
--73.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Revenue
148.33%7.49M
-75.97%37.00K
-100.00%0.00
67.12%122.00K
--3.02M
--154.00K
--51.00K
--73.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating expenses
-5.86%4.47M
-7.56%4.38M
-13.02%3.87M
-6.56%4.15M
-17.60%4.75M
-16.59%4.74M
-30.45%4.45M
-32.00%4.44M
-5.28%5.76M
-9.30%5.68M
-0.08%6.39M
-15.49%6.53M
2.89%6.08M
-10.92%6.26M
23.65%6.40M
66.22%7.72M
--5.91M
--7.03M
57.25%5.17M
24.76%4.64M
--3.29M
--3.72M
R&D expenses
18.29%3.09M
-21.33%2.17M
-23.98%2.16M
-1.87%2.25M
-7.63%2.61M
-6.27%2.75M
-26.38%2.84M
-43.58%2.30M
-30.43%2.83M
-28.60%2.94M
-19.82%3.85M
-33.82%4.07M
-7.90%4.07M
-19.55%4.11M
23.40%4.80M
115.63%6.15M
--4.42M
--5.11M
55.10%3.89M
-3.12%2.85M
--2.51M
--2.95M
Depreciation, depletion, and amortization
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-6.67%28.00K
----
--30.00K
Other operating expenses
--1.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating profit
274.58%3.02M
5.26%-4.34M
12.01%-3.87M
7.79%-4.02M
69.96%-1.73M
19.31%-4.58M
31.25%-4.40M
33.12%-4.36M
5.28%-5.76M
9.30%-5.68M
0.08%-6.39M
15.49%-6.53M
-2.89%-6.08M
10.92%-6.26M
-23.65%-6.40M
-66.22%-7.72M
---5.91M
---7.03M
-57.25%-5.17M
-24.76%-4.64M
---3.29M
---3.72M
Net non-operating interest income (expenses)
Non-operating interest income
3102.38%2.69M
-26.83%30.00K
-55.62%2.49M
3.40%578.00K
16.67%84.00K
-12.77%41.00K
1871.23%5.62M
698.57%559.00K
-89.76%72.00K
-96.95%47.00K
-45.09%285.00K
-90.62%70.00K
144.10%703.00K
4563.64%1.54M
-46.60%519.00K
702.15%746.00K
--288.00K
--33.00K
5975.00%972.00K
--93.00K
--16.00K
----
Non-operating interest expense
254.17%1.36M
7.11%241.00K
61.38%397.00K
-48.83%458.00K
110.99%384.00K
12.50%225.00K
-24.54%246.00K
51.69%895.00K
-65.98%182.00K
-11.11%200.00K
106.33%326.00K
719.44%590.00K
949.02%535.00K
-54.55%225.00K
-46.80%158.00K
-66.36%72.00K
--51.00K
--495.00K
7325.00%297.00K
494.44%214.00K
--4.00K
--36.00K
Gains from sale of securities
----
-686.36%-129.00K
----
----
----
128.21%22.00K
----
----
----
---78.00K
----
----
----
----
----
----
----
----
----
----
----
---19.00K
Special income (expenses)
----
79.08%-346.00K
----
----
----
---1.65M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income before tax
314.28%4.35M
21.43%-5.03M
-281.56%-1.77M
16.94%-3.90M
65.41%-2.03M
-8.28%-6.40M
115.17%976.00K
33.29%-4.70M
0.73%-5.87M
-19.47%-5.91M
-6.58%-6.43M
0.03%-7.04M
-4.23%-5.92M
33.96%-4.95M
-34.18%-6.04M
-47.86%-7.05M
---5.67M
---7.49M
-37.24%-4.50M
-26.15%-4.77M
---3.28M
---3.78M
Income tax
-176.04%-265.00K
2.01%-195.00K
11.93%-192.00K
-55.37%-275.00K
50.52%-96.00K
11.56%-199.00K
-12.37%-218.00K
-2.31%-177.00K
-10.86%-194.00K
-27.12%-225.00K
21.46%-194.00K
-113.08%-173.00K
58.82%-175.00K
73.54%-177.00K
39.31%-247.00K
363.55%1.32M
---425.00K
---669.00K
-126.11%-407.00K
-93.82%-502.00K
---180.00K
---259.00K
Income after tax
338.60%4.62M
22.06%-4.83M
-232.33%-1.58M
19.77%-3.63M
65.92%-1.94M
-9.06%-6.20M
119.13%1.19M
34.18%-4.52M
1.08%-5.68M
-19.19%-5.68M
-7.77%-6.24M
17.90%-6.87M
-9.33%-5.74M
30.08%-4.77M
-41.49%-5.79M
-96.29%-8.37M
---5.25M
---6.82M
-32.07%-4.09M
-21.17%-4.26M
---3.10M
---3.52M
Net income from continuous operations
338.66%4.62M
22.06%-4.83M
-232.33%-1.58M
19.77%-3.63M
65.92%-1.94M
-9.06%-6.20M
119.13%1.19M
34.18%-4.52M
1.08%-5.68M
-19.19%-5.68M
-7.77%-6.24M
17.90%-6.87M
-9.33%-5.74M
30.08%-4.77M
-41.49%-5.79M
-96.29%-8.37M
---5.25M
---6.82M
-32.07%-4.09M
-21.17%-4.26M
---3.10M
---3.52M
Other net gains and losses
--1.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net income attributable to controlling interests
338.66%4.62M
22.06%-4.83M
-232.33%-1.58M
19.77%-3.63M
65.92%-1.94M
-9.06%-6.20M
119.13%1.19M
34.18%-4.52M
1.08%-5.68M
-19.19%-5.68M
-7.77%-6.24M
17.90%-6.87M
-9.33%-5.74M
30.08%-4.77M
-41.49%-5.79M
-96.29%-8.37M
---5.25M
---6.82M
-32.07%-4.09M
-21.17%-4.26M
---3.10M
---3.52M
Net income attributable to common shareholders
338.66%4.62M
22.06%-4.83M
-232.33%-1.58M
19.77%-3.63M
65.92%-1.94M
-9.06%-6.20M
119.13%1.19M
34.18%-4.52M
1.08%-5.68M
-19.19%-5.68M
-7.77%-6.24M
17.90%-6.87M
-9.33%-5.74M
30.08%-4.77M
-41.49%-5.79M
-96.29%-8.37M
---5.25M
---6.82M
-32.07%-4.09M
-21.17%-4.26M
---3.10M
---3.52M
Basic earnings per share
141.46%0.01
86.72%-0.02
-211.68%-0.03
80.18%-0.31
98.29%-0.04
94.51%-0.12
101.06%0.03
45.34%-1.56
14.76%-2.05
-5.00%-2.10
3.18%-2.42
85.77%-2.85
82.16%-2.41
88.89%-2.00
78.26%-2.50
-77.75%-20.00
---13.50
---18.00
-42.49%-11.50
-22.77%-11.25
---8.07
---9.16
Diluted earnings per share
141.46%0.01
86.72%-0.02
-211.68%-0.03
80.18%-0.31
98.29%-0.04
94.51%-0.12
101.06%0.03
45.34%-1.56
14.76%-2.05
-5.00%-2.10
3.18%-2.42
85.77%-2.85
82.16%-2.41
88.89%-2.00
78.26%-2.50
-77.75%-20.00
---13.50
---18.00
-42.49%-11.50
-22.77%-11.25
---8.07
---9.16
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--

FAQs

What is the income statement?

The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.
KeyAI